Biora’s BT-600 novel drug-device may revolutionise targeted colon therapy

Biora’s BT-600 novel drug-device may revolutionise targeted colon therapy

Submitted by admin on February 22, 2024 - 11:39am
Source: 
Biopharma Reporter
News Tags: 
Biora Therapeutics
clinical trials
BTZ-600
drug-device combos
ulcerative colitis
Headline: 
Biora’s BT-600 novel drug-device may revolutionise targeted colon therapy
snippet: 

Biora Therapeutics recently announced the initiation of phase 1 clinical trials of BT-600, a novel drug-device combination for ulcerative colitis (UC) patients.

Do Not Allow Advertisers to Use My Personal information